CTLA4-Ig in combination with FTY720 promotes allograft survival in sensitized recipients
Open Access
- 4 May 2017
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 2 (9)
Abstract
Despite recent evidence of improved graft outcomes and safety, the high incidence of early acute cellular rejection with belatacept, a high-affinity CTLA4-Ig, has limited its use in clinical transplantation. Here we define how the incomplete control of endogenous donor-reactive memory T cells results in belatacept-resistant rejection in an experimental model of BALB/c.2W-OVA donor heart transplantation into C57BL/6 recipients presensitized to donor splenocytes. These sensitized mice harbored modestly elevated numbers of endogenous donor-specific memory T cells and alloantibodies compared with naive recipients. Continuous CTLA4-Ig treatment was unexpectedly efficacious at inhibiting endogenous graft-reactive T cell expansion but was unable to inhibit late CD4 + and CD8 + T cell infiltration into the allografts, and rejection was observed in 50% of recipients by day 35 after transplantation. When CTLA4-Ig was combined with the sphingosine 1-phosphate receptor-1 (S1PR1) functional antagonist FTY720, alloantibody production was inhibited and donor-specific IFN-γ–producing T cells were reduced to levels approaching nonsensitized tolerant recipients. Late T cell recruitment into the graft was also restrained, and graft survival improved with this combination therapy. These observations suggest that a rational strategy consisting of inhibiting memory T cell expansion and trafficking into the allograft with CTLA4-Ig and FTY720 can promote allograft survival in allosensitized recipients.Keywords
This publication has 62 references indexed in Scilit:
- Reversing Endogenous Alloreactive B Cell GC Responses With Anti-CD154 or CTLA-4IgAmerican Journal of Transplantation, 2013
- Distinct mechanisms mediate naïve and memory CD8 T-cell toleranceProceedings of the National Academy of Sciences, 2012
- Population Dynamics of Naive and Memory CD8 T Cell Responses after Antigen Stimulations In VivoThe Journal of Immunology, 2012
- Integrin Antagonists Prevent Costimulatory Blockade-Resistant Transplant Rejection by CD8+ Memory T CellsAmerican Journal of Transplantation, 2011
- Increased Sensitivity of Antigen-Experienced T Cells through the Enrichment of Oligomeric T Cell Receptor ComplexesImmunity, 2011
- Five-Year Safety and Efficacy of Belatacept in Renal TransplantationJournal of the American Society of Nephrology, 2010
- Memory T cells need CD28 costimulation to rememberSeminars in Immunology, 2009
- CD4 memory T cells divide poorly in response to antigen because of their cytokine profileProceedings of the National Academy of Sciences, 2008
- Antigen-specific precursor frequency impacts T cell proliferation, differentiation, and requirement for costimulationJournal of Experimental Medicine, 2007
- Naïve and Memory CD4 + T Cell Survival Controlled by Clonal AbundanceScience, 2006